MedTrace Logo

Effects of Mulligan Belt Traction Versus Fisted Traction in Patients With Lower Cervical Spine Radiculopathy

NCT07628439 · Status: ACTIVE_NOT_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 44

Last updated 2026-06-05

No results posted yet for this study

Summary

Individuals with a lower cervical spine radiculopathy diagnosis will undergo screening to determine their eligibility based on inclusion and exclusion criteria. Eligible participants will be asked for their informed consent

Conditions

  • Cervical Radiculopathy

Interventions

OTHER

muligan belt traction

Patient Position: * The Patient lies supine on the treatment table. * Head in neutral or slightly flexed position (according to comfort and symptoms). * Arms rest by the sides. Therapist Position: * Therapist stands at the head end of table, therapist places the middle finger on the concerned cervical segment. * To maintain joint contact and control movement at the level. Belt Placement: * The Mulligan belt is positioned at an angle to apply gentle traction targeting the lower cervical spine (C5-C7) (16) * Make sure there is no pressure on the throat or jaw. Application of Traction: * While maintaining contact at the target segment, therapist leans backward, to apply gentle sustained and controlled traction (distraction force) along the line of the cervical spine. * This help to open up the intervertebral foramen, reduce nerve compression and restore normal joint mechanics. (17) Duration: • Traction is applied for 10-30 seconds per repetition, repeated 3-5 times per session base

OTHER

Fisted traction

Sit upright in a chair with back support. • Keep your spine straight and head in a neutral position. Hand Placement: * One fist is placed at the upper chest\\sternum, acting as a fulcrum. * A towel is used between the fist and chest for comfort and positioning.(18) * The opposite hand is placed around the back of head (occiput). Traction Technique: * The head is pulled forward and down, guiding cervical flexion over the fist. * Maintain for 10-15 seconds, repeat 5-10 times, depending on comfort.

Sponsors & Collaborators

  • Riphah International University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
25 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-07-02
Primary Completion
2026-08-06
Completion
2026-09-04

Countries

  • Pakistan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07628439 on ClinicalTrials.gov